The bottom line So, how long does Wegovy stay in your system
Nothing is crossing the skin barrier at a dose that could act on GLP-1 receptors
20 However, a retrospective single-institution study showed that although other anti-diabetic medications (such as sodium-glucose cotransporter 2 inhibitors) were associated with a lower risk of sight-threatening DR, GLP-1RAs were not shown to confer any increased DR risk, clinical worsening, or increased intervention in DR
Still, compounded versions are not FDA-approved brand products
This article walks you through the clinical trial findings, common complaints, uncommon but important risks, and practical ways to lower the chance of trouble
Lancet 2025;405:701-14.ArticlePubMed REFERENCES PubReader ePub Link Cite this Article Cite this Article Close Download Citation Close XML Download Figure Fig